The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Covid-19 Diagnostic Market Research Report 2025
Synopsis
The global Covid-19 Diagnostic market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Covid-19 Diagnostic, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Covid-19 Diagnostic.
Report Scope
The Covid-19 Diagnostic market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Covid-19 Diagnostic market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Covid-19 Diagnostic companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Abbott Diagnostics
Accelerate Diagnostics
Ador Diagnostics
Akkoni Biosystems
Alveo Technologies
Applied BioCode
Aus Diagnostics
BD Diagnostics
Biocartis
BioFire Diagnostics
bioMérieux
Bio-Rad Laboratories
Bosch Healthcare Solutions GmbH
Cepheid
Co-Diagnostics
Cue Health
Curetis
Diagenode Diagnostics
Diascopic
Diasorin
Expedeon
Fusion Genomics.
GenePOC Diagnostics
GenMark Dx
Hologic
Immunexpress
Inflammatix
Invetech
Janssen Diagnostics
Segment by Type
Immunoassay
Genomic and WGS Role
rRT-PCR
Segment by Application
Hospital
Laboratory
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Covid-19 Diagnostic companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
The global Covid-19 Diagnostic market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Covid-19 Diagnostic, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Covid-19 Diagnostic.
Report Scope
The Covid-19 Diagnostic market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Covid-19 Diagnostic market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Covid-19 Diagnostic companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Abbott Diagnostics
Accelerate Diagnostics
Ador Diagnostics
Akkoni Biosystems
Alveo Technologies
Applied BioCode
Aus Diagnostics
BD Diagnostics
Biocartis
BioFire Diagnostics
bioMérieux
Bio-Rad Laboratories
Bosch Healthcare Solutions GmbH
Cepheid
Co-Diagnostics
Cue Health
Curetis
Diagenode Diagnostics
Diascopic
Diasorin
Expedeon
Fusion Genomics.
GenePOC Diagnostics
GenMark Dx
Hologic
Immunexpress
Inflammatix
Invetech
Janssen Diagnostics
Segment by Type
Immunoassay
Genomic and WGS Role
rRT-PCR
Segment by Application
Hospital
Laboratory
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Covid-19 Diagnostic companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Covid-19 Diagnostic Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Immunoassay
1.2.3 Genomic and WGS Role
1.2.4 rRT-PCR
1.3 Market by Application
1.3.1 Global Covid-19 Diagnostic Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospital
1.3.3 Laboratory
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Covid-19 Diagnostic Market Perspective (2019-2030)
2.2 Covid-19 Diagnostic Growth Trends by Region
2.2.1 Global Covid-19 Diagnostic Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Covid-19 Diagnostic Historic Market Size by Region (2019-2024)
2.2.3 Covid-19 Diagnostic Forecasted Market Size by Region (2025-2030)
2.3 Covid-19 Diagnostic Market Dynamics
2.3.1 Covid-19 Diagnostic Industry Trends
2.3.2 Covid-19 Diagnostic Market Drivers
2.3.3 Covid-19 Diagnostic Market Challenges
2.3.4 Covid-19 Diagnostic Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Covid-19 Diagnostic Players by Revenue
3.1.1 Global Top Covid-19 Diagnostic Players by Revenue (2019-2024)
3.1.2 Global Covid-19 Diagnostic Revenue Market Share by Players (2019-2024)
3.2 Global Covid-19 Diagnostic Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Covid-19 Diagnostic Revenue
3.4 Global Covid-19 Diagnostic Market Concentration Ratio
3.4.1 Global Covid-19 Diagnostic Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Covid-19 Diagnostic Revenue in 2023
3.5 Covid-19 Diagnostic Key Players Head office and Area Served
3.6 Key Players Covid-19 Diagnostic Product Solution and Service
3.7 Date of Enter into Covid-19 Diagnostic Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Covid-19 Diagnostic Breakdown Data by Type
4.1 Global Covid-19 Diagnostic Historic Market Size by Type (2019-2024)
4.2 Global Covid-19 Diagnostic Forecasted Market Size by Type (2025-2030)
5 Covid-19 Diagnostic Breakdown Data by Application
5.1 Global Covid-19 Diagnostic Historic Market Size by Application (2019-2024)
5.2 Global Covid-19 Diagnostic Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Covid-19 Diagnostic Market Size (2019-2030)
6.2 North America Covid-19 Diagnostic Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Covid-19 Diagnostic Market Size by Country (2019-2024)
6.4 North America Covid-19 Diagnostic Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Covid-19 Diagnostic Market Size (2019-2030)
7.2 Europe Covid-19 Diagnostic Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Covid-19 Diagnostic Market Size by Country (2019-2024)
7.4 Europe Covid-19 Diagnostic Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Covid-19 Diagnostic Market Size (2019-2030)
8.2 Asia-Pacific Covid-19 Diagnostic Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Covid-19 Diagnostic Market Size by Region (2019-2024)
8.4 Asia-Pacific Covid-19 Diagnostic Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Covid-19 Diagnostic Market Size (2019-2030)
9.2 Latin America Covid-19 Diagnostic Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Covid-19 Diagnostic Market Size by Country (2019-2024)
9.4 Latin America Covid-19 Diagnostic Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Covid-19 Diagnostic Market Size (2019-2030)
10.2 Middle East & Africa Covid-19 Diagnostic Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Covid-19 Diagnostic Market Size by Country (2019-2024)
10.4 Middle East & Africa Covid-19 Diagnostic Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Abbott Diagnostics
11.1.1 Abbott Diagnostics Company Detail
11.1.2 Abbott Diagnostics Business Overview
11.1.3 Abbott Diagnostics Covid-19 Diagnostic Introduction
11.1.4 Abbott Diagnostics Revenue in Covid-19 Diagnostic Business (2019-2024)
11.1.5 Abbott Diagnostics Recent Development
11.2 Accelerate Diagnostics
11.2.1 Accelerate Diagnostics Company Detail
11.2.2 Accelerate Diagnostics Business Overview
11.2.3 Accelerate Diagnostics Covid-19 Diagnostic Introduction
11.2.4 Accelerate Diagnostics Revenue in Covid-19 Diagnostic Business (2019-2024)
11.2.5 Accelerate Diagnostics Recent Development
11.3 Ador Diagnostics
11.3.1 Ador Diagnostics Company Detail
11.3.2 Ador Diagnostics Business Overview
11.3.3 Ador Diagnostics Covid-19 Diagnostic Introduction
11.3.4 Ador Diagnostics Revenue in Covid-19 Diagnostic Business (2019-2024)
11.3.5 Ador Diagnostics Recent Development
11.4 Akkoni Biosystems
11.4.1 Akkoni Biosystems Company Detail
11.4.2 Akkoni Biosystems Business Overview
11.4.3 Akkoni Biosystems Covid-19 Diagnostic Introduction
11.4.4 Akkoni Biosystems Revenue in Covid-19 Diagnostic Business (2019-2024)
11.4.5 Akkoni Biosystems Recent Development
11.5 Alveo Technologies
11.5.1 Alveo Technologies Company Detail
11.5.2 Alveo Technologies Business Overview
11.5.3 Alveo Technologies Covid-19 Diagnostic Introduction
11.5.4 Alveo Technologies Revenue in Covid-19 Diagnostic Business (2019-2024)
11.5.5 Alveo Technologies Recent Development
11.6 Applied BioCode
11.6.1 Applied BioCode Company Detail
11.6.2 Applied BioCode Business Overview
11.6.3 Applied BioCode Covid-19 Diagnostic Introduction
11.6.4 Applied BioCode Revenue in Covid-19 Diagnostic Business (2019-2024)
11.6.5 Applied BioCode Recent Development
11.7 Aus Diagnostics
11.7.1 Aus Diagnostics Company Detail
11.7.2 Aus Diagnostics Business Overview
11.7.3 Aus Diagnostics Covid-19 Diagnostic Introduction
11.7.4 Aus Diagnostics Revenue in Covid-19 Diagnostic Business (2019-2024)
11.7.5 Aus Diagnostics Recent Development
11.8 BD Diagnostics
11.8.1 BD Diagnostics Company Detail
11.8.2 BD Diagnostics Business Overview
11.8.3 BD Diagnostics Covid-19 Diagnostic Introduction
11.8.4 BD Diagnostics Revenue in Covid-19 Diagnostic Business (2019-2024)
11.8.5 BD Diagnostics Recent Development
11.9 Biocartis
11.9.1 Biocartis Company Detail
11.9.2 Biocartis Business Overview
11.9.3 Biocartis Covid-19 Diagnostic Introduction
11.9.4 Biocartis Revenue in Covid-19 Diagnostic Business (2019-2024)
11.9.5 Biocartis Recent Development
11.10 BioFire Diagnostics
11.10.1 BioFire Diagnostics Company Detail
11.10.2 BioFire Diagnostics Business Overview
11.10.3 BioFire Diagnostics Covid-19 Diagnostic Introduction
11.10.4 BioFire Diagnostics Revenue in Covid-19 Diagnostic Business (2019-2024)
11.10.5 BioFire Diagnostics Recent Development
11.11 bioMérieux
11.11.1 bioMérieux Company Detail
11.11.2 bioMérieux Business Overview
11.11.3 bioMérieux Covid-19 Diagnostic Introduction
11.11.4 bioMérieux Revenue in Covid-19 Diagnostic Business (2019-2024)
11.11.5 bioMérieux Recent Development
11.12 Bio-Rad Laboratories
11.12.1 Bio-Rad Laboratories Company Detail
11.12.2 Bio-Rad Laboratories Business Overview
11.12.3 Bio-Rad Laboratories Covid-19 Diagnostic Introduction
11.12.4 Bio-Rad Laboratories Revenue in Covid-19 Diagnostic Business (2019-2024)
11.12.5 Bio-Rad Laboratories Recent Development
11.13 Bosch Healthcare Solutions GmbH
11.13.1 Bosch Healthcare Solutions GmbH Company Detail
11.13.2 Bosch Healthcare Solutions GmbH Business Overview
11.13.3 Bosch Healthcare Solutions GmbH Covid-19 Diagnostic Introduction
11.13.4 Bosch Healthcare Solutions GmbH Revenue in Covid-19 Diagnostic Business (2019-2024)
11.13.5 Bosch Healthcare Solutions GmbH Recent Development
11.14 Cepheid
11.14.1 Cepheid Company Detail
11.14.2 Cepheid Business Overview
11.14.3 Cepheid Covid-19 Diagnostic Introduction
11.14.4 Cepheid Revenue in Covid-19 Diagnostic Business (2019-2024)
11.14.5 Cepheid Recent Development
11.15 Co-Diagnostics
11.15.1 Co-Diagnostics Company Detail
11.15.2 Co-Diagnostics Business Overview
11.15.3 Co-Diagnostics Covid-19 Diagnostic Introduction
11.15.4 Co-Diagnostics Revenue in Covid-19 Diagnostic Business (2019-2024)
11.15.5 Co-Diagnostics Recent Development
11.16 Cue Health
11.16.1 Cue Health Company Detail
11.16.2 Cue Health Business Overview
11.16.3 Cue Health Covid-19 Diagnostic Introduction
11.16.4 Cue Health Revenue in Covid-19 Diagnostic Business (2019-2024)
11.16.5 Cue Health Recent Development
11.17 Curetis
11.17.1 Curetis Company Detail
11.17.2 Curetis Business Overview
11.17.3 Curetis Covid-19 Diagnostic Introduction
11.17.4 Curetis Revenue in Covid-19 Diagnostic Business (2019-2024)
11.17.5 Curetis Recent Development
11.18 Diagenode Diagnostics
11.18.1 Diagenode Diagnostics Company Detail
11.18.2 Diagenode Diagnostics Business Overview
11.18.3 Diagenode Diagnostics Covid-19 Diagnostic Introduction
11.18.4 Diagenode Diagnostics Revenue in Covid-19 Diagnostic Business (2019-2024)
11.18.5 Diagenode Diagnostics Recent Development
11.19 Diascopic
11.19.1 Diascopic Company Detail
11.19.2 Diascopic Business Overview
11.19.3 Diascopic Covid-19 Diagnostic Introduction
11.19.4 Diascopic Revenue in Covid-19 Diagnostic Business (2019-2024)
11.19.5 Diascopic Recent Development
11.20 Diasorin
11.20.1 Diasorin Company Detail
11.20.2 Diasorin Business Overview
11.20.3 Diasorin Covid-19 Diagnostic Introduction
11.20.4 Diasorin Revenue in Covid-19 Diagnostic Business (2019-2024)
11.20.5 Diasorin Recent Development
11.21 Expedeon
11.21.1 Expedeon Company Detail
11.21.2 Expedeon Business Overview
11.21.3 Expedeon Covid-19 Diagnostic Introduction
11.21.4 Expedeon Revenue in Covid-19 Diagnostic Business (2019-2024)
11.21.5 Expedeon Recent Development
11.22 Fusion Genomics.
11.22.1 Fusion Genomics. Company Detail
11.22.2 Fusion Genomics. Business Overview
11.22.3 Fusion Genomics. Covid-19 Diagnostic Introduction
11.22.4 Fusion Genomics. Revenue in Covid-19 Diagnostic Business (2019-2024)
11.22.5 Fusion Genomics. Recent Development
11.23 GenePOC Diagnostics
11.23.1 GenePOC Diagnostics Company Detail
11.23.2 GenePOC Diagnostics Business Overview
11.23.3 GenePOC Diagnostics Covid-19 Diagnostic Introduction
11.23.4 GenePOC Diagnostics Revenue in Covid-19 Diagnostic Business (2019-2024)
11.23.5 GenePOC Diagnostics Recent Development
11.24 GenMark Dx
11.24.1 GenMark Dx Company Detail
11.24.2 GenMark Dx Business Overview
11.24.3 GenMark Dx Covid-19 Diagnostic Introduction
11.24.4 GenMark Dx Revenue in Covid-19 Diagnostic Business (2019-2024)
11.24.5 GenMark Dx Recent Development
11.25 Hologic
11.25.1 Hologic Company Detail
11.25.2 Hologic Business Overview
11.25.3 Hologic Covid-19 Diagnostic Introduction
11.25.4 Hologic Revenue in Covid-19 Diagnostic Business (2019-2024)
11.25.5 Hologic Recent Development
11.26 Immunexpress
11.26.1 Immunexpress Company Detail
11.26.2 Immunexpress Business Overview
11.26.3 Immunexpress Covid-19 Diagnostic Introduction
11.26.4 Immunexpress Revenue in Covid-19 Diagnostic Business (2019-2024)
11.26.5 Immunexpress Recent Development
11.27 Inflammatix
11.27.1 Inflammatix Company Detail
11.27.2 Inflammatix Business Overview
11.27.3 Inflammatix Covid-19 Diagnostic Introduction
11.27.4 Inflammatix Revenue in Covid-19 Diagnostic Business (2019-2024)
11.27.5 Inflammatix Recent Development
11.28 Invetech
11.28.1 Invetech Company Detail
11.28.2 Invetech Business Overview
11.28.3 Invetech Covid-19 Diagnostic Introduction
11.28.4 Invetech Revenue in Covid-19 Diagnostic Business (2019-2024)
11.28.5 Invetech Recent Development
11.29 Janssen Diagnostics
11.29.1 Janssen Diagnostics Company Detail
11.29.2 Janssen Diagnostics Business Overview
11.29.3 Janssen Diagnostics Covid-19 Diagnostic Introduction
11.29.4 Janssen Diagnostics Revenue in Covid-19 Diagnostic Business (2019-2024)
11.29.5 Janssen Diagnostics Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesList of Tables
Table 1. Global Covid-19 Diagnostic Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Immunoassay
Table 3. Key Players of Genomic and WGS Role
Table 4. Key Players of rRT-PCR
Table 5. Global Covid-19 Diagnostic Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 6. Global Covid-19 Diagnostic Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 7. Global Covid-19 Diagnostic Market Size by Region (2019-2024) & (US$ Million)
Table 8. Global Covid-19 Diagnostic Market Share by Region (2019-2024)
Table 9. Global Covid-19 Diagnostic Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 10. Global Covid-19 Diagnostic Market Share by Region (2025-2030)
Table 11. Covid-19 Diagnostic Market Trends
Table 12. Covid-19 Diagnostic Market Drivers
Table 13. Covid-19 Diagnostic Market Challenges
Table 14. Covid-19 Diagnostic Market Restraints
Table 15. Global Covid-19 Diagnostic Revenue by Players (2019-2024) & (US$ Million)
Table 16. Global Covid-19 Diagnostic Market Share by Players (2019-2024)
Table 17. Global Top Covid-19 Diagnostic Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Covid-19 Diagnostic as of 2023)
Table 18. Ranking of Global Top Covid-19 Diagnostic Companies by Revenue (US$ Million) in 2023
Table 19. Global 5 Largest Players Market Share by Covid-19 Diagnostic Revenue (CR5 and HHI) & (2019-2024)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Covid-19 Diagnostic Product Solution and Service
Table 22. Date of Enter into Covid-19 Diagnostic Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Covid-19 Diagnostic Market Size by Type (2019-2024) & (US$ Million)
Table 25. Global Covid-19 Diagnostic Revenue Market Share by Type (2019-2024)
Table 26. Global Covid-19 Diagnostic Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 27. Global Covid-19 Diagnostic Revenue Market Share by Type (2025-2030)
Table 28. Global Covid-19 Diagnostic Market Size by Application (2019-2024) & (US$ Million)
Table 29. Global Covid-19 Diagnostic Revenue Market Share by Application (2019-2024)
Table 30. Global Covid-19 Diagnostic Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 31. Global Covid-19 Diagnostic Revenue Market Share by Application (2025-2030)
Table 32. North America Covid-19 Diagnostic Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 33. North America Covid-19 Diagnostic Market Size by Country (2019-2024) & (US$ Million)
Table 34. North America Covid-19 Diagnostic Market Size by Country (2025-2030) & (US$ Million)
Table 35. Europe Covid-19 Diagnostic Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 36. Europe Covid-19 Diagnostic Market Size by Country (2019-2024) & (US$ Million)
Table 37. Europe Covid-19 Diagnostic Market Size by Country (2025-2030) & (US$ Million)
Table 38. Asia-Pacific Covid-19 Diagnostic Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 39. Asia-Pacific Covid-19 Diagnostic Market Size by Region (2019-2024) & (US$ Million)
Table 40. Asia-Pacific Covid-19 Diagnostic Market Size by Region (2025-2030) & (US$ Million)
Table 41. Latin America Covid-19 Diagnostic Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 42. Latin America Covid-19 Diagnostic Market Size by Country (2019-2024) & (US$ Million)
Table 43. Latin America Covid-19 Diagnostic Market Size by Country (2025-2030) & (US$ Million)
Table 44. Middle East & Africa Covid-19 Diagnostic Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 45. Middle East & Africa Covid-19 Diagnostic Market Size by Country (2019-2024) & (US$ Million)
Table 46. Middle East & Africa Covid-19 Diagnostic Market Size by Country (2025-2030) & (US$ Million)
Table 47. Abbott Diagnostics Company Detail
Table 48. Abbott Diagnostics Business Overview
Table 49. Abbott Diagnostics Covid-19 Diagnostic Product
Table 50. Abbott Diagnostics Revenue in Covid-19 Diagnostic Business (2019-2024) & (US$ Million)
Table 51. Abbott Diagnostics Recent Development
Table 52. Accelerate Diagnostics Company Detail
Table 53. Accelerate Diagnostics Business Overview
Table 54. Accelerate Diagnostics Covid-19 Diagnostic Product
Table 55. Accelerate Diagnostics Revenue in Covid-19 Diagnostic Business (2019-2024) & (US$ Million)
Table 56. Accelerate Diagnostics Recent Development
Table 57. Ador Diagnostics Company Detail
Table 58. Ador Diagnostics Business Overview
Table 59. Ador Diagnostics Covid-19 Diagnostic Product
Table 60. Ador Diagnostics Revenue in Covid-19 Diagnostic Business (2019-2024) & (US$ Million)
Table 61. Ador Diagnostics Recent Development
Table 62. Akkoni Biosystems Company Detail
Table 63. Akkoni Biosystems Business Overview
Table 64. Akkoni Biosystems Covid-19 Diagnostic Product
Table 65. Akkoni Biosystems Revenue in Covid-19 Diagnostic Business (2019-2024) & (US$ Million)
Table 66. Akkoni Biosystems Recent Development
Table 67. Alveo Technologies Company Detail
Table 68. Alveo Technologies Business Overview
Table 69. Alveo Technologies Covid-19 Diagnostic Product
Table 70. Alveo Technologies Revenue in Covid-19 Diagnostic Business (2019-2024) & (US$ Million)
Table 71. Alveo Technologies Recent Development
Table 72. Applied BioCode Company Detail
Table 73. Applied BioCode Business Overview
Table 74. Applied BioCode Covid-19 Diagnostic Product
Table 75. Applied BioCode Revenue in Covid-19 Diagnostic Business (2019-2024) & (US$ Million)
Table 76. Applied BioCode Recent Development
Table 77. Aus Diagnostics Company Detail
Table 78. Aus Diagnostics Business Overview
Table 79. Aus Diagnostics Covid-19 Diagnostic Product
Table 80. Aus Diagnostics Revenue in Covid-19 Diagnostic Business (2019-2024) & (US$ Million)
Table 81. Aus Diagnostics Recent Development
Table 82. BD Diagnostics Company Detail
Table 83. BD Diagnostics Business Overview
Table 84. BD Diagnostics Covid-19 Diagnostic Product
Table 85. BD Diagnostics Revenue in Covid-19 Diagnostic Business (2019-2024) & (US$ Million)
Table 86. BD Diagnostics Recent Development
Table 87. Biocartis Company Detail
Table 88. Biocartis Business Overview
Table 89. Biocartis Covid-19 Diagnostic Product
Table 90. Biocartis Revenue in Covid-19 Diagnostic Business (2019-2024) & (US$ Million)
Table 91. Biocartis Recent Development
Table 92. BioFire Diagnostics Company Detail
Table 93. BioFire Diagnostics Business Overview
Table 94. BioFire Diagnostics Covid-19 Diagnostic Product
Table 95. BioFire Diagnostics Revenue in Covid-19 Diagnostic Business (2019-2024) & (US$ Million)
Table 96. BioFire Diagnostics Recent Development
Table 97. bioMérieux Company Detail
Table 98. bioMérieux Business Overview
Table 99. bioMérieux Covid-19 Diagnostic Product
Table 100. bioMérieux Revenue in Covid-19 Diagnostic Business (2019-2024) & (US$ Million)
Table 101. bioMérieux Recent Development
Table 102. Bio-Rad Laboratories Company Detail
Table 103. Bio-Rad Laboratories Business Overview
Table 104. Bio-Rad Laboratories Covid-19 Diagnostic Product
Table 105. Bio-Rad Laboratories Revenue in Covid-19 Diagnostic Business (2019-2024) & (US$ Million)
Table 106. Bio-Rad Laboratories Recent Development
Table 107. Bosch Healthcare Solutions GmbH Company Detail
Table 108. Bosch Healthcare Solutions GmbH Business Overview
Table 109. Bosch Healthcare Solutions GmbH Covid-19 Diagnostic Product
Table 110. Bosch Healthcare Solutions GmbH Revenue in Covid-19 Diagnostic Business (2019-2024) & (US$ Million)
Table 111. Bosch Healthcare Solutions GmbH Recent Development
Table 112. Cepheid Company Detail
Table 113. Cepheid Business Overview
Table 114. Cepheid Covid-19 Diagnostic Product
Table 115. Cepheid Revenue in Covid-19 Diagnostic Business (2019-2024) & (US$ Million)
Table 116. Cepheid Recent Development
Table 117. Co-Diagnostics Company Detail
Table 118. Co-Diagnostics Business Overview
Table 119. Co-Diagnostics Covid-19 Diagnostic Product
Table 120. Co-Diagnostics Revenue in Covid-19 Diagnostic Business (2019-2024) & (US$ Million)
Table 121. Co-Diagnostics Recent Development
Table 122. Cue Health Company Detail
Table 123. Cue Health Business Overview
Table 124. Cue Health Covid-19 Diagnostic Product
Table 125. Cue Health Revenue in Covid-19 Diagnostic Business (2019-2024) & (US$ Million)
Table 126. Cue Health Recent Development
Table 127. Curetis Company Detail
Table 128. Curetis Business Overview
Table 129. Curetis Covid-19 Diagnostic Product
Table 130. Curetis Revenue in Covid-19 Diagnostic Business (2019-2024) & (US$ Million)
Table 131. Curetis Recent Development
Table 132. Diagenode Diagnostics Company Detail
Table 133. Diagenode Diagnostics Business Overview
Table 134. Diagenode Diagnostics Covid-19 Diagnostic Product
Table 135. Diagenode Diagnostics Revenue in Covid-19 Diagnostic Business (2019-2024) & (US$ Million)
Table 136. Diagenode Diagnostics Recent Development
Table 137. Diascopic Company Detail
Table 138. Diascopic Business Overview
Table 139. Diascopic Covid-19 Diagnostic Product
Table 140. Diascopic Revenue in Covid-19 Diagnostic Business (2019-2024) & (US$ Million)
Table 141. Diascopic Recent Development
Table 142. Diasorin Company Detail
Table 143. Diasorin Business Overview
Table 144. Diasorin Covid-19 Diagnostic Product
Table 145. Diasorin Revenue in Covid-19 Diagnostic Business (2019-2024) & (US$ Million)
Table 146. Diasorin Recent Development
Table 147. Expedeon Company Detail
Table 148. Expedeon Business Overview
Table 149. Expedeon Covid-19 Diagnostic Product
Table 150. Expedeon Revenue in Covid-19 Diagnostic Business (2019-2024) & (US$ Million)
Table 151. Expedeon Recent Development
Table 152. Fusion Genomics. Company Detail
Table 153. Fusion Genomics. Business Overview
Table 154. Fusion Genomics. Covid-19 Diagnostic Product
Table 155. Fusion Genomics. Revenue in Covid-19 Diagnostic Business (2019-2024) & (US$ Million)
Table 156. Fusion Genomics. Recent Development
Table 157. GenePOC Diagnostics Company Detail
Table 158. GenePOC Diagnostics Business Overview
Table 159. GenePOC Diagnostics Covid-19 Diagnostic Product
Table 160. GenePOC Diagnostics Revenue in Covid-19 Diagnostic Business (2019-2024) & (US$ Million)
Table 161. GenePOC Diagnostics Recent Development
Table 162. GenMark Dx Company Detail
Table 163. GenMark Dx Business Overview
Table 164. GenMark Dx Covid-19 Diagnostic Product
Table 165. GenMark Dx Revenue in Covid-19 Diagnostic Business (2019-2024) & (US$ Million)
Table 166. GenMark Dx Recent Development
Table 167. Hologic Company Detail
Table 168. Hologic Business Overview
Table 169. Hologic Covid-19 Diagnostic Product
Table 170. Hologic Revenue in Covid-19 Diagnostic Business (2019-2024) & (US$ Million)
Table 171. Hologic Recent Development
Table 172. Immunexpress Company Detail
Table 173. Immunexpress Business Overview
Table 174. Immunexpress Covid-19 Diagnostic Product
Table 175. Immunexpress Revenue in Covid-19 Diagnostic Business (2019-2024) & (US$ Million)
Table 176. Immunexpress Recent Development
Table 177. Inflammatix Company Detail
Table 178. Inflammatix Business Overview
Table 179. Inflammatix Covid-19 Diagnostic Product
Table 180. Inflammatix Revenue in Covid-19 Diagnostic Business (2019-2024) & (US$ Million)
Table 181. Inflammatix Recent Development
Table 182. Invetech Company Detail
Table 183. Invetech Business Overview
Table 184. Invetech Covid-19 Diagnostic Product
Table 185. Invetech Revenue in Covid-19 Diagnostic Business (2019-2024) & (US$ Million)
Table 186. Invetech Recent Development
Table 187. Janssen Diagnostics Company Detail
Table 188. Janssen Diagnostics Business Overview
Table 189. Janssen Diagnostics Covid-19 Diagnostic Product
Table 190. Janssen Diagnostics Revenue in Covid-19 Diagnostic Business (2019-2024) & (US$ Million)
Table 191. Janssen Diagnostics Recent Development
Table 192. Research Programs/Design for This Report
Table 193. Key Data Information from Secondary Sources
Table 194. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Covid-19 Diagnostic Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Covid-19 Diagnostic Market Share by Type: 2023 VS 2030
Figure 3. Immunoassay Features
Figure 4. Genomic and WGS Role Features
Figure 5. rRT-PCR Features
Figure 6. Global Covid-19 Diagnostic Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 7. Global Covid-19 Diagnostic Market Share by Application: 2023 VS 2030
Figure 8. Hospital Case Studies
Figure 9. Laboratory Case Studies
Figure 10. Covid-19 Diagnostic Report Years Considered
Figure 11. Global Covid-19 Diagnostic Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 12. Global Covid-19 Diagnostic Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 13. Global Covid-19 Diagnostic Market Share by Region: 2023 VS 2030
Figure 14. Global Covid-19 Diagnostic Market Share by Players in 2023
Figure 15. Global Top Covid-19 Diagnostic Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Covid-19 Diagnostic as of 2023)
Figure 16. The Top 10 and 5 Players Market Share by Covid-19 Diagnostic Revenue in 2023
Figure 17. North America Covid-19 Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 18. North America Covid-19 Diagnostic Market Share by Country (2019-2030)
Figure 19. United States Covid-19 Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 20. Canada Covid-19 Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. Europe Covid-19 Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. Europe Covid-19 Diagnostic Market Share by Country (2019-2030)
Figure 23. Germany Covid-19 Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. France Covid-19 Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. U.K. Covid-19 Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. Italy Covid-19 Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. Russia Covid-19 Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Nordic Countries Covid-19 Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Asia-Pacific Covid-19 Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Asia-Pacific Covid-19 Diagnostic Market Share by Region (2019-2030)
Figure 31. China Covid-19 Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Japan Covid-19 Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. South Korea Covid-19 Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Southeast Asia Covid-19 Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. India Covid-19 Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Australia Covid-19 Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Latin America Covid-19 Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Latin America Covid-19 Diagnostic Market Share by Country (2019-2030)
Figure 39. Mexico Covid-19 Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Brazil Covid-19 Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Middle East & Africa Covid-19 Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Middle East & Africa Covid-19 Diagnostic Market Share by Country (2019-2030)
Figure 43. Turkey Covid-19 Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Saudi Arabia Covid-19 Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Abbott Diagnostics Revenue Growth Rate in Covid-19 Diagnostic Business (2019-2024)
Figure 46. Accelerate Diagnostics Revenue Growth Rate in Covid-19 Diagnostic Business (2019-2024)
Figure 47. Ador Diagnostics Revenue Growth Rate in Covid-19 Diagnostic Business (2019-2024)
Figure 48. Akkoni Biosystems Revenue Growth Rate in Covid-19 Diagnostic Business (2019-2024)
Figure 49. Alveo Technologies Revenue Growth Rate in Covid-19 Diagnostic Business (2019-2024)
Figure 50. Applied BioCode Revenue Growth Rate in Covid-19 Diagnostic Business (2019-2024)
Figure 51. Aus Diagnostics Revenue Growth Rate in Covid-19 Diagnostic Business (2019-2024)
Figure 52. BD Diagnostics Revenue Growth Rate in Covid-19 Diagnostic Business (2019-2024)
Figure 53. Biocartis Revenue Growth Rate in Covid-19 Diagnostic Business (2019-2024)
Figure 54. BioFire Diagnostics Revenue Growth Rate in Covid-19 Diagnostic Business (2019-2024)
Figure 55. bioMérieux Revenue Growth Rate in Covid-19 Diagnostic Business (2019-2024)
Figure 56. Bio-Rad Laboratories Revenue Growth Rate in Covid-19 Diagnostic Business (2019-2024)
Figure 57. Bosch Healthcare Solutions GmbH Revenue Growth Rate in Covid-19 Diagnostic Business (2019-2024)
Figure 58. Cepheid Revenue Growth Rate in Covid-19 Diagnostic Business (2019-2024)
Figure 59. Co-Diagnostics Revenue Growth Rate in Covid-19 Diagnostic Business (2019-2024)
Figure 60. Cue Health Revenue Growth Rate in Covid-19 Diagnostic Business (2019-2024)
Figure 61. Curetis Revenue Growth Rate in Covid-19 Diagnostic Business (2019-2024)
Figure 62. Diagenode Diagnostics Revenue Growth Rate in Covid-19 Diagnostic Business (2019-2024)
Figure 63. Diascopic Revenue Growth Rate in Covid-19 Diagnostic Business (2019-2024)
Figure 64. Diasorin Revenue Growth Rate in Covid-19 Diagnostic Business (2019-2024)
Figure 65. Expedeon Revenue Growth Rate in Covid-19 Diagnostic Business (2019-2024)
Figure 66. Fusion Genomics. Revenue Growth Rate in Covid-19 Diagnostic Business (2019-2024)
Figure 67. GenePOC Diagnostics Revenue Growth Rate in Covid-19 Diagnostic Business (2019-2024)
Figure 68. GenMark Dx Revenue Growth Rate in Covid-19 Diagnostic Business (2019-2024)
Figure 69. Hologic Revenue Growth Rate in Covid-19 Diagnostic Business (2019-2024)
Figure 70. Immunexpress Revenue Growth Rate in Covid-19 Diagnostic Business (2019-2024)
Figure 71. Inflammatix Revenue Growth Rate in Covid-19 Diagnostic Business (2019-2024)
Figure 72. Invetech Revenue Growth Rate in Covid-19 Diagnostic Business (2019-2024)
Figure 73. Janssen Diagnostics Revenue Growth Rate in Covid-19 Diagnostic Business (2019-2024)
Figure 74. Bottom-up and Top-down Approaches for This Report
Figure 75. Data Triangulation
Figure 76. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
